Levosimendan appeared to increase in-hospital survival rates, although no long-term survival benefit was reported, among patients with comorbid heart failure and connective tissue disease–associated ...

The most tremendous advancements in the field of cardiovascular medicine over the past two decades, I’d argue, have been in the areas of structural heart disease and imaging. In the 1960s and 1970s, ...